Ieq Capital LLC Makes New Investment in Agilent Technologies, Inc. $A

Ieq Capital LLC purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 176,837 shares of the medical research company’s stock, valued at approximately $23,489,000.

A number of other institutional investors also recently modified their holdings of A. Fiduciary Trust Co boosted its holdings in shares of Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after buying an additional 77 shares during the period. Sapient Capital LLC raised its holdings in Agilent Technologies by 4.2% in the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock worth $240,000 after acquiring an additional 85 shares during the period. Plan A Wealth LLC lifted its position in Agilent Technologies by 3.2% during the 4th quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock worth $403,000 after acquiring an additional 92 shares during the last quarter. UNIVEST FINANCIAL Corp lifted its position in Agilent Technologies by 1.3% during the 2nd quarter. UNIVEST FINANCIAL Corp now owns 7,145 shares of the medical research company’s stock worth $949,000 after acquiring an additional 93 shares during the last quarter. Finally, IHT Wealth Management LLC boosted its holdings in Agilent Technologies by 4.9% during the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after acquiring an additional 96 shares during the period.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $159.25 on Friday. The firm has a market capitalization of $44.98 billion, a PE ratio of 31.98, a PEG ratio of 2.77 and a beta of 1.25. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.51. The business’s 50 day moving average is $137.57 and its 200-day moving average is $126.23.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business had revenue of $1.83 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period in the prior year, the company posted $1.31 earnings per share. Agilent Technologies’s revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 6.03 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently commented on A. Sanford C. Bernstein started coverage on Agilent Technologies in a research note on Friday, June 26th. They issued an “outperform” rating and a $155.00 price objective on the stock. HSBC lowered their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Barclays upped their price target on Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Morgan Stanley increased their price objective on Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Finally, Jefferies Financial Group initiated coverage on shares of Agilent Technologies in a research note on Thursday, July 9th. They issued a “hold” rating and a $135.00 price objective on the stock. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Agilent Technologies presently has an average rating of “Moderate Buy” and an average target price of $160.24.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.